• 1
    Lee WM. Acute liver failure. Semin Respir Crit Care Med 2012; 33: 36-45.
  • 2
    Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SHB, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137: 947-954.
  • 3
    Bernal W, Hyyrylainen A, Gera A, Audimoolam VK, McPhail MJW, Auzinger G. Lessons from look-back in acute liver failure? A single-centre experience of 3300 patients. J Hepatol; doi:10.1016/j.jhep.2013.02.010.
  • 4
    Stravitz RT, Kramer AH, Davern T, Shaikh AOS, Caldwell SH, Mehta RL, et al. Intensive care of patients with acute liver failure: recommendations of the US Acute Liver Failure Study Group. Crit Care Med 2007; 35: 2498-2508.
  • 5
    Vaquero J, Fontana RJ, Larson AM, Bass NMT, Davern TJ, Shakil AO, et al. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl 2005; 11: 1581-1589.
  • 6
    Rolando N, Gimson A, Wade J, Philpott-Howard J, Casewell M, Williams R. Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure. Hepatology 1993; 17: 196-201.
  • 7
    Davenport A, Will EJ, Davidson AM. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med 1993; 21: 328-338.
  • 8
    Lee WM, Hynan LS, Rossaro L, Fontana RJ, Stravitz RT, Larson AM, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 2009; 137: 856-864.
  • 9
    Stravitz RT, Lisman T, Luketic VA, Sterling RK, Puri P, Fuchs M, et al. Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. J Hepatol 2012; 56: 129-136.
  • 10
    Organ Procurement and Transplantation Network. Policy 3.6: allocation of livers. Accessed May 2013.
  • 11
    O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-445.
  • 12
    Donaldson BW, Gopinath R, Wanless IR, Phillips MJ, Cameron R, Roberts EA, et al. The role of transjugular liver biopsy in fulminant liver failure: relation to other prognostic indicators. Hepatology 1993; 18: 1370-1374.
  • 13
    Singhal A, Vadlamudi S, Stokes, K, Cassidy FP, Corn A, Shrago SS, et al. Liver histology as predictor of outcome in patients with acute liver failure. Transpl Int 2012; 25: 658-662.
  • 14
    Berg CL, Steffick DE, Edwards EB, Heimbach JK, Magee JC, Washburn WK, et al. Liver and intestine transplantation in the United States 1998–2007. Am J Transplant 2009; 9: 907-931.
  • 15
    Reddy KR, Schilsky ML, Stravitz R, Ellerbe C, Durkalski V, Fontana RJ, et al. Liver transplantation (LT) for acute liver failure (ALF): results from the NIH Acute Liver Failure Study Group (ALFSG) [abstract]. Hepatology 2012; 56(suppl 1): 246A-247A.
  • 16
    Kjaergard LL, Liu J, Als-Nielsen B, Gluud C. Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review. JAMA 2003; 289: 217-222.
  • 17
    Campsen J, Blei AT, Emond JC, Everhart JE, Freise CE, Lok AS, et al. Outcomes of living donor liver transplantation for acute liver failure: the Adult-to-Adult Living Donor Liver Transplantation Cohort Study. Liver Transpl 2008; 14: 1273-1280.